Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythemia in childhood

J J Michiels1, P J Van Genderen

  • 1European Working Group on Myeloproliferative Disorders, Goodheart Institute, Rotterdam, The Netherlands.

Seminars in Thrombosis and Hemostasis
|January 1, 1997
PubMed
Summary

Essential thrombocythemia (ET) in children presents with high platelet counts and bleeding risks. Non-leukemogenic agents like anagrelide are preferred treatments for childhood ET.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Pearls in travellers and migrants.

Journal of travel medicine·2018
Same author

A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.

International angiology : a journal of the International Union of Angiology·2014
Same author

Letter to the editor: seafarers: a new risk group for meticillin-resistant Staphylococcus aureus (MRSA).

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2013
Same author

Plasmodium knowlesi infection imported to Germany, January 2013.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2013
Same author

Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013

Area of Science:

  • Hematology
  • Pediatric Oncology

Background:

  • Essential thrombocythemia (ET) diagnosis involves specific hematologic and bone marrow criteria.
  • Childhood ET shares features with adult forms but requires distinct clinical considerations.

Purpose of the Study:

  • To review diagnostic markers and clinical manifestations of ET in childhood.
  • To evaluate treatment options for pediatric ET, focusing on safety and efficacy.

Main Methods:

  • Review of 11 reported childhood ET cases.
  • Analysis of hematologic parameters, clinical symptoms, and thrombohemorrhagic events.

Main Results:

  • All cases exhibited platelet counts >1000 x 10(9)/L, with most showing leukocytosis and splenomegaly.
  • Common manifestations included bleeding (6/8 symptomatic cases) and microcirculatory disturbances.
  • Microcirculatory issues were not reported below 1000 x 10(9)/L platelet count.

Conclusions:

  • Anagrelide and alpha-interferon are recommended non-leukemogenic treatments for childhood ET.
  • Anagrelide demonstrates better tolerability than alpha-interferon.
  • Leukemogenic agents like hydroxyurea and busulfan should be used judiciously.

Related Experiment Videos